Can Wegovy cause itchy eyes? What patients are reporting and what the evidence shows

Is there a link between Wegovy and itchy or irritated eyes?

The short answer is: not a direct, well-established one. The recognised side-effect profile for semaglutide is led by gastrointestinal symptoms (nausea, loose stools, constipation, burping and occasional fatigue) and the NHS medicines information for semaglutide doesn't list eye itching among them. That matters because the NHS list is drawn from clinical trial data covering tens of thousands of patient-weeks of exposure.

That said, absence from a standard side-effect list doesn't mean a symptom is unrelated to treatment. There's a common misconception worth clearing up gently here: many people assume that if something isn't in the leaflet it can't be caused by the medicine. The reality is subtler. Phase-3 trials are designed to detect effects that occur in a meaningful proportion of participants; rarer individual reactions are gathered mainly through post-market surveillance, which is exactly why the MHRA runs its Yellow Card reporting scheme. If you've noticed itchy eyes since starting Wegovy, reporting that experience via Yellow Card adds to the evidence base, even if the cause turns out to be unrelated.

Some patients who describe itchy eyes on semaglutide may actually be experiencing a form of ocular dryness that feels itchy rather than gritty. That distinction matters clinically, so it's worth thinking about whether the sensation is more of an itch, a burn or a general irritation before describing it to a prescriber. If you want a broader picture of whether semaglutide can make you itchy in ways that go beyond the eyes, that question is explored in more detail separately.

Could semaglutide affect the eyes indirectly?

There are a few plausible indirect pathways worth knowing about, even though none establishes a definitive causal chain for itching specifically.

First, the appetite suppression that makes Wegovy effective can significantly reduce calorie and fluid intake, particularly in the early weeks of treatment. Reduced hydration affects mucous membranes throughout the body, and the eyes are no exception. Tear film quality can deteriorate when overall fluid intake drops, producing a dry, itchy or scratchy sensation. If you've cut back sharply on both food and drink since starting treatment, that's worth flagging. The fix may be as straightforward as drinking more water consistently throughout the day.

Second, for people with type 2 diabetes or blood-sugar fluctuations, any significant and rapid change in metabolic status can sometimes affect vision transiently. This is more associated with diabetic retinopathy rather than general itching, but it reinforces why prescribers always want a clear picture of a patient's background conditions. Semaglutide is licensed for weight management as well as type 2 diabetes, and the population taking it is varied.

People who are exploring related questions (such as whether semaglutide is connected to skin or surface irritation more broadly) may find it useful to read about itchy skin reported with Wegovy and how the mechanisms there compare. Eye symptoms and skin symptoms can sometimes share an inflammatory or allergic basis.

When should you tell someone about eye symptoms on Wegovy?

Mild, occasional itchiness that comes and goes and responds to over-the-counter lubricating drops probably warrants a note for your next routine check-in with your prescriber rather than urgent action. Persistent or worsening symptoms are a different matter.

Seek prompt medical advice if you notice sudden changes in vision, pain inside the eye, significant redness, light sensitivity, or any symptom that feels qualitatively different from ordinary irritation. For people with diabetes or a history of retinal problems, the advice from NHS guidance is clear: tell your healthcare team about any eye changes, because blood-glucose shifts during weight-loss treatment can occasionally trigger or worsen existing diabetic eye disease.

It's also worth noting the context of dose increases. Symptoms that emerge or intensify in the days after moving to a higher dose of Wegovy (whether gastrointestinal, dermatological or otherwise) are more likely to be treatment-related than symptoms that have been stable for weeks. A full overview of how semaglutide works and what to expect during each stage of treatment can help you recognise what's typical and what's worth escalating.

If you have a general question about a symptom that isn't addressed in your patient information leaflet, the team at nume's aftercare support is available seven days a week, that's part of what the service includes, at no extra charge.

Does the type of Wegovy formulation make a difference?

The injectable Wegovy and the newer Wegovy tablet (oral semaglutide, approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) both contain semaglutide as the active ingredient. The side-effect profiles differ mainly in the gastrointestinal domain (the oral version reported a higher incidence of GI symptoms in trials, likely because of the way the tablet reaches the gut) but no specific difference in eye-related effects has been established between the two formulations at this stage. Our guidance on semaglutide and itchy symptoms covers what is currently known across both formulations for patients who want to understand this further.

If you are considering switching formulations, or are new to treatment and weighing up which route suits you, that decision belongs to a prescriber who can review your full medical history. Our semaglutide treatment information covers both formulations alongside what the clinical evidence shows for each.

Separately, if dry-eye symptoms are your primary concern rather than itching, there's specific information about Wegovy and dry eyes that addresses that question directly.

Understanding the full range of what semaglutide treatment involves (from how it works to what symptoms are worth monitoring) is also covered in the weight-loss treatment overview on the site. And if you'd like to speak with a prescriber about whether Wegovy is suitable for you, or to ask about a symptom you've noticed, starting a free consultation puts you in front of a GPhC-registered clinician, not an automated triage tool.